Social Media Influencers and Pharmaceutical Products: A Review of Risks, Misuse, and Regulatory Challenges

Authors

  • Aditya D. Deohans Shraddha Institute of Pharmacy, Kondala Zambre, Washim 444505.
  • Mayur D. Nandeshwar Shraddha Institute of Pharmacy, Kondala Zambre, Washim 444505.
  • Sakshi A. Kharate Assistant Professor, Shraddha Institute of Pharmacy, Kondala Zambre, Washim 444505.
  • Dr Swati P. Deshmukh Principal, Department of Pharmacology Shraddha Institute of Pharmacy, Kondala Zambre, Washim 444505.

DOI:

https://doi.org/10.5281/zenodo.20068600

Keywords:

Social Media Influencers, Influencer Marketing, Pharmaceutical and Cosmetic Products, Consumer Behavior, Adverse Drug Reactions (ADRs)

Abstract

The rise of social media has greatly changed how pharmaceutical and cosmetic products are promoted and used. Influencers have become the main people that Generation Z listens to when making decisions about skincare, over-the-counter medicines, and health supplements. However, since many influencers don’t have proper medical training, they often share incomplete or wrong information. This can lead to people using products incorrectly and experiencing side effects like skin irritation, acne, and allergies. To look into this issue, a study was done with 172 participants. It found that many consumers trust influencer advice without checking if it’s backed by scientific evidence. This gap between marketing and medical safety shows major problems in the enforcement of India’s regulations, including the Drugs and Cosmetics Act (1940), Consumer Protection Act (2019), and the Bharatiya Nyaya Sanhita (2023). The study concludes that protecting public health needs several steps: stronger regulation, holding influencers accountable, and raising awareness among the public. Most importantly, it suggests creating a digital platform with reliable, science-based information about drugs to connect digital marketing with safe consumer practices.

References

Downloads

Published

2026-05-07

How to Cite

Social Media Influencers and Pharmaceutical Products: A Review of Risks, Misuse, and Regulatory Challenges. (2026). JOURNAL UGC-CARE IJCRT (2349-3194) | ISSN Approved Journal, 16(2), 51339-513362. https://doi.org/10.5281/zenodo.20068600

Most read articles by the same author(s)